FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202496952> ?p ?o ?g. }

• W3202496952 abstract "Mesenchymal stem cells (MSCs) are favourable treatments for ischaemic diseases; however, MSCs from diabetic patients are not useful for this purpose. Recent studies have shown that the expression of miR-34a is significantly increased in patients with hyperglycaemia; the precise role of miR-34a in MSCs in diabetes needs to be clarified. The aim of this study is to determine the precise role of miR-34a in MSCs exposed to hyperglycaemia and in recovery heart function after myocardial infarction (MI) in diabetes mellitus (DM) rats. DM rat models were established by high-fat diet combined with streptozotocin (STZ) injection. MSCs were isolated from the bone marrow of donor rats. Chronic culture of MSCs under high glucose was used to mimic the DM micro-environment. The role of miR-34a in regulating cell viability, senescence and paracrine effects were investigated using a cell counting kit-8 (CCK-8) assay, senescence-associated β-galactosidase (SA-β-gal) staining and vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) ELISA, respectively. The expression of autophagy- and senescence-associated proteins in MSCs and silent information regulator 1 (SIRT1) and forkhead box class O 3a (FoxO3a) were analysed by western blotting. Autophagic bodies were analysed by transmission electron microscopy (TEM). The MI model was established by left anterior descending coronary artery (LAD) ligation, and then, the rats were transplanted with differentially treated MSCs intramuscularly at sites around the border zone of the infarcted heart. Thereafter, cardiac function in rats in each group was detected via cardiac ultrasonography at 1 week and 3 weeks after surgery. The infarct size was determined through a 2,3,5-triphenyltetrazolium chloride (TTC) staining assay, while myocardial fibrosis was assessed by Masson staining. The results of the current study showed that miR-34a was significantly increased under chronic hyperglycaemia exposure. Overexpression of miR-34a was significantly associated with impaired cell viability, exacerbated senescence and disrupted cell paracrine capacity. Moreover, we found that the mechanism underlying miR-34a-mediated deterioration of MSCs exposed to high glucose involved the activation of the SIRT1/FoxO3a autophagy pathway. Further analysis showed that miR-34a inhibitor-treated MSC transplantation could improve cardiac function and decrease the scar area in DM rats. Our study demonstrates for the first time that miR-34a mediates the deterioration of MSCs’ functions under hyperglycaemia. The underlying mechanism may involve the SIRT1/FoxO3a autophagy signalling pathway. Thus, inhibition of miR-34a might have important therapeutic implications in MSC-based therapies for myocardial infarction in DM patients." @default.
• W3202496952 created "2021-10-11" @default.
• W3202496952 creator A5002551693 @default.
• W3202496952 creator A5030691366 @default.
• W3202496952 creator A5049211211 @default.
• W3202496952 creator A5056438587 @default.
• W3202496952 creator A5059412974 @default.
• W3202496952 date "2021-10-07" @default.
• W3202496952 modified "2023-10-16" @default.
• W3202496952 title "Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway" @default.
• W3202496952 cites W1715909735 @default.
• W3202496952 cites W1827349666 @default.
• W3202496952 cites W1936454852 @default.
• W3202496952 cites W1965673106 @default.
• W3202496952 cites W1973472942 @default.
• W3202496952 cites W1980309647 @default.
• W3202496952 cites W1982933214 @default.
• W3202496952 cites W1983517713 @default.
• W3202496952 cites W2006426795 @default.
• W3202496952 cites W2018559323 @default.
• W3202496952 cites W2038332924 @default.
• W3202496952 cites W2057217856 @default.
• W3202496952 cites W2058768220 @default.
• W3202496952 cites W2070334783 @default.
• W3202496952 cites W2101042911 @default.
• W3202496952 cites W2101080348 @default.
• W3202496952 cites W2110795504 @default.
• W3202496952 cites W2112911107 @default.
• W3202496952 cites W2131707839 @default.
• W3202496952 cites W2133409607 @default.
• W3202496952 cites W2135378280 @default.
• W3202496952 cites W2152602200 @default.
• W3202496952 cites W2165398964 @default.
• W3202496952 cites W2168391904 @default.
• W3202496952 cites W2200200899 @default.
• W3202496952 cites W2280212630 @default.
• W3202496952 cites W2296292832 @default.
• W3202496952 cites W2331274940 @default.
• W3202496952 cites W2366061453 @default.
• W3202496952 cites W2402236206 @default.
• W3202496952 cites W2499445998 @default.
• W3202496952 cites W2536337124 @default.
• W3202496952 cites W2595652125 @default.
• W3202496952 cites W2615764617 @default.
• W3202496952 cites W2757005172 @default.
• W3202496952 cites W2775091161 @default.
• W3202496952 cites W2789268442 @default.
• W3202496952 cites W2802090363 @default.
• W3202496952 cites W2804911404 @default.
• W3202496952 cites W2889312210 @default.
• W3202496952 cites W2898897540 @default.
• W3202496952 cites W2903135877 @default.
• W3202496952 cites W2912751133 @default.
• W3202496952 cites W2916417739 @default.
• W3202496952 cites W2918030842 @default.
• W3202496952 cites W2941999541 @default.
• W3202496952 cites W3012374780 @default.
• W3202496952 cites W3012468862 @default.
• W3202496952 doi "https://doi.org/10.1186/s13287-021-02606-0" @default.
• W3202496952 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8499566" @default.
• W3202496952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34620210" @default.
• W3202496952 hasPublicationYear "2021" @default.
• W3202496952 type Work @default.
• W3202496952 sameAs 3202496952 @default.
• W3202496952 citedByCount "0" @default.
• W3202496952 crossrefType "journal-article" @default.
• W3202496952 hasAuthorship W3202496952A5002551693 @default.
• W3202496952 hasAuthorship W3202496952A5030691366 @default.
• W3202496952 hasAuthorship W3202496952A5049211211 @default.
• W3202496952 hasAuthorship W3202496952A5056438587 @default.
• W3202496952 hasAuthorship W3202496952A5059412974 @default.
• W3202496952 hasBestOaLocation W32024969521 @default.
• W3202496952 hasConcept C104317684 @default.
• W3202496952 hasConcept C145059251 @default.
• W3202496952 hasConcept C185592680 @default.
• W3202496952 hasConcept C190283241 @default.
• W3202496952 hasConcept C198826908 @default.
• W3202496952 hasConcept C203522944 @default.
• W3202496952 hasConcept C28328180 @default.
• W3202496952 hasConcept C502942594 @default.
• W3202496952 hasConcept C55493867 @default.
• W3202496952 hasConcept C71924100 @default.
• W3202496952 hasConcept C86803240 @default.
• W3202496952 hasConcept C95444343 @default.
• W3202496952 hasConceptScore W3202496952C104317684 @default.
• W3202496952 hasConceptScore W3202496952C145059251 @default.
• W3202496952 hasConceptScore W3202496952C185592680 @default.
• W3202496952 hasConceptScore W3202496952C190283241 @default.
• W3202496952 hasConceptScore W3202496952C198826908 @default.
• W3202496952 hasConceptScore W3202496952C203522944 @default.
• W3202496952 hasConceptScore W3202496952C28328180 @default.
• W3202496952 hasConceptScore W3202496952C502942594 @default.
• W3202496952 hasConceptScore W3202496952C55493867 @default.
• W3202496952 hasConceptScore W3202496952C71924100 @default.
• W3202496952 hasConceptScore W3202496952C86803240 @default.
• W3202496952 hasConceptScore W3202496952C95444343 @default.
• W3202496952 hasIssue "1" @default.
• W3202496952 hasLocation W32024969521 @default.
• W3202496952 hasLocation W32024969522 @default.
• W3202496952 hasLocation W32024969523 @default.

• next